Bormioli Pharma, a global producer in the pharma packaging market, is strengthening its presence in the U.S., establishing a new legal entity—Bormioli Pharma United States Inc.
 
This decision is part of the company’s five-year strategic plan and sees the opening of a commercial branch in Philadelphia, PA hosting an on-site sales team dedicated to the North American market.
 
“Through our internationalization strategy, we aim to be closer to our customers, providing a more effective service for the biggest pharma market in the world,” said Andrea Lodetti, chief executive officer, Bormioli Pharma. “That’s part of our growth strategy plan, aiming to make Bormioli Pharma a truly global player, able to answer to the market challenges with high value-added pharma packaging solutions.”
 
Bormioli Pharma said it also plans to strengthen its overseas logistics support through the opening a new warehouse in the U.S., scheduled by the first half of 2019.